deltatrials
Completed PHASE1 INTERVENTIONAL 3-arm NCT03028285

Study of Safety and Tolerability of UNIFUZOL (Solution for Infusions) in Healthy Volunteers

Open Randomized Study of the Safety, Tolerability, and Pharmacokinetic Parameters of UNIFUZOL® (Solution for Infusions, 1.4%, Manufactured by NTFFPOLYSAN Ltd.,Russia) in Healthy Volunteers at Different Rates of Administration (Phase I)

Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company

Conditions Peripheral Vascular Disease
Interventions arginine sodium succinate
Updated 9 times since 2017 Last updated: Jul 10, 2020 Started: Jul 15, 2016 Primary completion: Jan 19, 2017 Completion: Jan 26, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Peripheral Vascular Disease, this trial is completed. The trial is conducted by POLYSAN Scientific & Technological Pharmaceutical Company and has accumulated 9 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Feb 2017 – ~Feb 2018 · 12 months · monthly snapshotRecruiting~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshotCompleted~Jun 2018 – ~Mar 2019 · 9 months · monthly snapshotCompleted~Mar 2019 – ~Aug 2020 · 17 months · monthly snapshotCompleted~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE1

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  5. Aug 2020 — Jan 2021 [monthly]

    Completed PHASE1

▶ Show 4 earlier versions

  1. Mar 2019 — Aug 2020 [monthly]

    Completed PHASE1

  2. Jun 2018 — Mar 2019 [monthly]

    Completed PHASE1

  3. Feb 2018 — Jun 2018 [monthly]

    Completed PHASE1

    Status: Recruiting → Completed

  4. Feb 2017 — Feb 2018 [monthly]

    Recruiting PHASE1

    First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • POLYSAN Scientific & Technological Pharmaceutical Company
Data source: POLYSAN Scientific & Technological Pharmaceutical Company

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations